Medtronic's (MDT) IN.PACT Admiral DCB Receives FDA Approval

September 13, 2016 11:03 AM EDT Send to a Friend
Medtronic plc (NYSE: MDT) announced that the U.S. Food and Drug Administration (FDA) approved the IN.PACT Admiral drug-coated balloon (DCB) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login